Cabo Verde vs Niger: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cabo Verde
0.7%
in 2024
Niger
3.2%
in 2024
Cabo Verde rank
1st
Niger rank
3rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cabo Verde
- Niger
How they compare
Niger currently reports 3.2% against 0.7% in Cabo Verde, a difference of 2.5%.
That makes Niger's figure about 4.6 times Cabo Verde's.
Across all 10 years both countries report, Niger has been ahead every year.
Cabo Verde ranks 1st and Niger ranks 3rd of 6 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cabo Verde | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 2.6% | 1.8% | Niger |
| 2020s | 0.6% | 3.4% | 2.8% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cabo Verde or Niger?
- Niger, at 3.2% against 0.7% in Cabo Verde as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cabo Verde and Niger?
- 2.5%, with Niger ahead.
- How many years of comparable data are there for Cabo Verde and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do Cabo Verde and Niger rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cabo Verde ranks 1st and Niger ranks 3rd of 6 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.